Therapeutic Asset Ratings
3,272 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Palbociclib
Cervical Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Palbociclib
Carcinoma Of Esophagus
National Cancer Institute (NCI)
P2
CCC
(53)
Palbociclib
Gastric Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Palbociclib
Head And Neck Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Palbociclib
Hematopoietic And Lymphoid Cell Neoplasm
National Cancer Institute (NCI)
P2
CCC
(53)
Palbociclib
Histiocytic Sarcoma
National Cancer Institute (NCI)
P2
CCC
(53)
Palbociclib
Juvenile Xanthogranuloma
National Cancer Institute (NCI)
P2
CCC
(53)
Palbociclib
Renal Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Palbociclib
Lung Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Palbociclib
Female Reproductive Organ Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Palbociclib
Uterine Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Palbociclib
Central Nervous System Neoplasm
National Cancer Institute (NCI)
P2
CCC
(53)
Palbociclib
Skin Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Palbociclib
Wilms Tumor
National Cancer Institute (NCI)
P2
CCC
(53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P2
CCC
(53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Urinary Bladder Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Breast Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Cervical Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Colon Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Endometrial Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Carcinoma Of Esophagus
National Cancer Institute (NCI)
P2
CCC
(53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Exocrine Pancreatic Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Gastric Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Head And Neck Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Hematopoietic And Lymphoid Cell Neoplasm
National Cancer Institute (NCI)
P2
CCC
(53)
Showing 1876 to 1900 of 3,272 assets
Previous
Page 76 of 131
Next